Novartis to buy AveXis in $8.7bn gene-therapy deal – Reuters.com
Reuters.com |
Novartis to buy AveXis in $8.7bn gene–therapy deal
Reuters.com Novartis to buy AveXis in $8.7bn gene–therapy deal. Swiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports. TRANSCRIPT + … |
